Partner
Eric Moessinger
Partner, ND Capital
- Firm
- ND Capital
- Title
- Partner
- Role
- Partner
- Known as
- Investor
Claim, correct or request removal
Record updated 17 September 2026
About
Eric joined +ND Capital in 2008 and was the first employee of our Silicon Valley office. He is focused on life sciences investments. Eric is currently a board member of Emulate, Visby Medical, AIRNA, Partillion, Osasuna and a board observer of Lightcast, IonPath and Inscripta. He was previously a board member of Icosavax (Acquired by AZ), Serotiny (Acquired by J&J), SQZ Biotech (NYSE: SQZ), and observed on the boards of ARMO (acquired by Lilly) and Twist (Nasdaq: TWST). Eric also helped lead +ND Capital’s investments in Orca, Octant and Nutcracker.
Is this you? Remove my profile
Loading relationship preview